Stanislav Kozlovski, PA
Medical · Atlanta, GANPI 1437767910
Payments from drug & device makers
Across 63 payments — averaging $15.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$228
- AbbVie$179
- AstraZeneca$64
- Lilly USA, LLC$62
- Otsuka America Pharmaceutical, Inc.$59
- Biohaven Pharmaceuticals, Inc.$54
- plus $303 from 10 others
What the payments were for
- Food & beverage$949100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $228 |
| AbbVie | 14 | $179 |
| AstraZeneca | 5 | $64 |
| Lilly USA, LLC | 4 | $62 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Biohaven Pharmaceuticals, Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Astellas Pharma US Inc | 3 | $43 |
| Amarin Pharma, Inc. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Organon | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| Eisai Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$949 in reported general payments places this provider in the 50th percentile of 950 medical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 22 | $132 |
| Losartan Potassium | 12 | $111 |
| Atorvastatin Calcium | 17 | $70 |
| Hydrochlorothiazide | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other medical in Atlanta
- Kimberly OrleckAtlanta$727K
- Danna Dennis-CalderAtlanta$87K
- Ferrina ShethAtlanta$49K
- Adriana RuizAtlanta$39K
- Punam PunjaAtlanta$31K
- Adrienne AndersonAtlanta$25K
- Jeremiah RobinsonAtlanta$23K
- Steven SchmittAtlanta$15K
- Taylor WeintraubAtlanta$15K
- Margaret SellersAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.